First Patient Receives Gene Therapy for Rare Liver Disorder

An investigational gene therapy for glycogen storage disease (GSD) was administered to a patient for the first time ever on July 24. Dr. David Weinstein and his team administered the one-time, 30-minute infusion at UConn John Dempsey Hospital. The gene therapy gives real hope to patients who suffer from the potentially deadly GSD - a rare childhood genetic disorder impacting the liver’s storage and release of sugar. Watch the video to meet Jerrod and see him receive this groundbreaking therapy.

[@tinaisbell4389]

Prayers for success!! My great Niece and Nephew both have GSD.

[@hennylawless9708]

You got it jerrod🤙I’m here for you bro

[@rayenchannel1589]

2020 any news please !

[@carlosvillarreal5052]

Your a true hero. My daughter has gsd.

[@gericacammack1588]

I love you a miracle is happening your sister Daisy Cammack

[@dreboy7688]

Gerica Cammick loo I P.O.l l.p. lil I o li